Home » Panacos Sells HIV Drug Candidate
Panacos Sells HIV Drug Candidate
Panacos Pharmaceuticals Inc., a Watertown biotechnology company, said it has sold the rights and assets of bevirimat, a potential HIV drug, for $7 million.
boston.com
boston.com
Upcoming Events
-
07May
-
14May
-
30May